Prevention of murine antiphospholipid syndrome by BAFF blockade
Open Access
- 29 August 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (9), 2824-2834
- https://doi.org/10.1002/art.23764
Abstract
Objective This study was undertaken to determine whether BAFF blockade can be used to prevent or treat antiphospholipid syndrome in a mouse model. Methods Eight‐ and 12‐week‐old (NZW × BXSB)F1 mice were treated with BAFF‐R‐Ig or TACI‐Ig alone or in addition to a short course of CTLA‐4Ig. Mice were monitored for thrombocytopenia and proteinuria. Sera were tested for anticardiolipin antibodies (aCL), BAFF levels, and levels of soluble vascular cell adhesion molecule and E‐selectin. Mice were killed at 17, 22, or 32 weeks of age, and kidneys and hearts were subjected to histologic examination. Spleen cells were phenotyped and enzyme‐linked immunospot assays for autoantibody‐producing B cells were performed. Results Both BAFF‐R‐Ig and TACI‐Ig prevented disease onset and significantly prolonged survival. Treated mice had significantly smaller spleens than controls, with fewer B cells and fewer activated and memory T cells. BAFF blockade did not prevent the development of aCL, and there was only a modest delay in the development of thrombocytopenia. However, treated mice had significantly less nephritis and myocardial infarcts than did controls. Conclusion Our findings suggest that aCL are generated in the germinal center, which is relatively independent of BAFF. Effector function of antiplatelet antibodies was only modestly affected by BAFF blockade. In contrast, myocardial infarctions were prevented, suggesting that triggering of thromboses requires both autoantibodies and mediators of inflammation. Similarly, renal damage requires both immune complexes and effector cells. The dissociation between autoantibody production and inflammation that may occur with B cell–depleting therapies underscores the role of B cells as effector cells in the autoimmune response.Keywords
This publication has 41 references indexed in Scilit:
- Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literatureLupus, 2008
- BAFF and MyD88 signals promote a lupuslike disease independent of T cellsThe Journal of Experimental Medicine, 2007
- Toll-like Receptor 7-Dependent Loss of B Cell Tolerance in Pathogenic Autoantibody Knockin MiceImmunity, 2006
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006
- Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene DuplicationScience, 2006
- Similarities and differences between selective and nonselective BAFF blockade in murine SLEJCI Insight, 2006
- Dendritic Cells Control B Cell Growth and DifferentiationPublished by S. Karger AG ,2004
- Splenic T Zone Development Is B Cell DependentThe Journal of Experimental Medicine, 2001
- From T to B and back again: positive feedback in systemic autoimmune diseaseNature Reviews Immunology, 2001
- Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the SyndromeJournal of Autoimmunity, 2000